Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -105,370 | -63,468 | -29,586 | -28,778 | -106,001 |
| Depreciation Amortization | -7,183 | -4,777 | -2,898 | -1,119 | -249 |
| Accounts payable and accrued liabilities | 2,732 | 1,635 | 3,493 | 537 | -1,444 |
| Other Working Capital | 5,632 | -1,331 | -2,380 | 28,438 | -2,339 |
| Other Operating Activity | 31,658 | 22,790 | 12,365 | 7,353 | 25,953 |
| Operating Cash Flow | $-72,531 | $-45,151 | $-19,006 | $6,431 | $-84,080 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -86,124 | -44,197 | -59,658 | -60,447 | -45,837 |
| PPE Investments | -445 | -265 | -265 | -195 | -148 |
| Investing Cash Flow | $-86,569 | $-44,462 | $-59,923 | $-60,642 | $-45,985 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 25,000 |
| Common Stock Issued | 345,772 | 343,043 | 1,760 | 93,070 | -450 |
| Other Financing Activity | 0 | 0 | 92,360 | 0 | 0 |
| Financing Cash Flow | $345,772 | $343,043 | $94,120 | $93,070 | $24,550 |
| Beginning Cash Position | 20,291 | 20,291 | 20,291 | 20,291 | 125,806 |
| End Cash Position | 206,963 | 273,721 | 35,482 | 59,150 | 20,291 |
| Net Cash Flow | $186,672 | $253,430 | $15,191 | $38,859 | $-105,515 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,531 | -45,151 | -19,006 | 6,431 | -84,080 |
| Capital Expenditure | -445 | -265 | -265 | -195 | -148 |
| Free Cash Flow | -72,976 | -45,416 | -19,271 | 6,236 | -84,228 |